ROCK SPRINGS CAPITAL MANAGEMENT LP Celldex Therapeutics, Inc. Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$11.85M
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

+4.27%
quarter

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +25.67% 86.12K shares 2.80M $28.11 421.60K
Q2 2022 share Increase +244.73% 238.16K shares 5.72M $26.96 335.47K
Q1 2022 share Increase 0.00% 97.31K shares 3.31M $34.06 97.31K